Gleneagles Global Hospitals Heart and Lung Transplant Program in Karnataka

IMT News Desk
IMT News Desk
· 5 min read
L-R Mr Thomas Mathew, Dr Yogesh Kothari, Patient Mohammed Rafi, Dr K Ravindranath, Dr Thasee Pillay, Dr Sandeep AS, Dr Ravindranath Reddy

Gleneagles Global Hospitals is delighted to announce the launch of their Heart and Lung Transplant program in Karnataka in order to serve the local community and promote the benefits of these procedures. This initiative will help boost the healthcare sector of the state while also build awareness regarding end-stage heart and lung conditions, providing options to those who may not have had viable treatment options in the past.

The heart and the lungs are among the most important organs of the body. When either of these organs start failing to perform as required, the whole medical status of the body is compromised. If left untreated, it could cause irreversible damage to other organs as they depend on these two organs to properly function. With the launch of this program, Gleneagles Global Hospitals brings to Karnataka the experience of Dr Thasee Pillay, a world renowned cardiothoracic surgeon, and his team of medical professionals experienced in the field of transplants. As a member of the international society for minimally invasive cardiothoracic surgery and former clinical director of the cardiothoracic services overseeing Adult and Paediatric Surgery, Anaesthesia and intensive Care, Cardiopulmonary Transplantation and ex director of the royal college of surgeons, Dr Pillay brings with him 2 decades of experience in the field of transplants, and has been a part of over 500 transplants in the UK. His experience and training will be a great asset to the heart and lung transplant scenario in Karnataka, especially for those patients who have had to travel long distances to receive treatment in the past.

Recently, BGS Gleneagles Global Hospitals treated a patient suffering from dilated cardiomyopathy, which had resulted in his prolonged bed ridden state and multiple hospitalisations due to its escalation to cardiac failure. His day-to-day activities and professional life had severely been hampered due to his condition. After matching him with a suitable donor, the cardiac transplant team successfully performed the transplant. The patient withstood the procedure well and his recovery in the hospital went forward smoothly. He is currently doing well and has been able to go back to his normal life.

Dr Thasee Pillay, Advisor & Sr. Consultant Cardiac & Cardiopulmonary Transplant at BGS Gleneagles Global Hospitals, said, “Heart transplantation is a major, critical and complex surgery. It should only be considered if the surgery is going to improve the recipient’s chance of survival or quality of life, post-transplant. Over the years, results have shown that the survival rates of cardiac failure patients have risen from 20% to 80% due to the availability of this procedure, making it a true life-saver and game changer for those patients suffering from heart failure.”

Dr Sandeep HS, Consultant Transplant Pulmonologist at BGS Gleneagles Global Hospitals, said, “There is no way through which lost lung function can be restored completely in respiratory diseases like COPD and ILDs. Despite medical management these diseases continue to progress and the patients eventually end up with respiratory failure. Lung transplantation is the only option to improve quality of life and increase the longevity in such situations. Lung Transplantation is being done worldwide for more than 30 years and the time has come now for our countrymen to utilise this life saving treatment modality.”

With the launch of this program, the medical team at Gleneagles Global Hospitals will be available for consultations, assessment, and performance of transplants in the state of Karnataka at their hospitals. Should the necessity present itself, these doctors will also be at hand to do outreach programs to help remote areas of the state. These transplant procedures will follow internationally established protocols, from assessing whether the patient’s condition necessitates a transplant, to assessing the patient’s ability to withstand the procedure, inclusive of evaluation of the damaged organ as well as other organ functions, to identifying and minimising all potential risks that could arise from the performance of these transplant procedures.

Dr K Ravindranath, Chairman, Gleneagles Global Hospitals Group said, “With the launch of this transplant program, we hope to educate the public on the benefits of undergoing transplants. These medical procedures offer patients a new lease of life, and a better quality of life than the one they were going through while on medical management. Gleneagles Global Hospitals Group is a pioneering institution in multi organ transplantation in India with cutting edge technology for transplant procedures since it is a world-class transplant center. With our team of experienced medical professionals and a laboratory devoted to transplant immunology, I am sure that this program will be able to benefit all members of the society who need transplant for Heart failure.”

The BGS Gleneagles Global Hospitals in Bengaluru is a state-of-the-art, NABH facility with expertise in multi-disciplinary tertiary specialties. With over 500-beds, the hospital is one of the largest of its kind in Bengaluru and consists of 14-operation theatres, most advanced imaging facilities and has one of the largest liver ICUs in the country. The hospital caters to several key specialties including oncology, neurosurgery, liver diseases and various others. It brings advanced technologies that drive new and more effective treatments.

BGS Gleneagles Global Hospitals caters to several overseas patients from around the world suffering from various disorders such as liver ailments, kidney failures, breast cancer, leukemia, neurological disorders amongst others. Gleneagles Global Hospitals, Bengaluru enjoys an international repute as a center of excellence for advanced clinical care. BGS Gleneagles Global Hospitals is your trusted partner for all your healthcare needs.

Read Next

India Willing to Open Its Market to High-Quality Innovative Pharma Products, Says Commerce Minister Goyal
News
June 9, 2026

India Willing to Open Its Market to High-Quality Innovative Pharma Products, Says Commerce Minister Goyal

India is prepared to welcome high-quality and innovative pharmaceutical products from the global industry in exchange for preferential access for its domestic drug exports, Commerce and Industry Minister Piyush Goyal announced on Monday. Speaking at the Pharmaceutical Promotion Council Ambassadors meeting, Goyal indicated that India’s pharmaceutical market size could potentially expand to USD 120 billion […]
Article by: IMT News Desk
AIIMS Study Reveals How Air Pollution Damages the Placenta and Changes Babies Before Birth
News
June 9, 2026

AIIMS Study Reveals How Air Pollution Damages the Placenta and Changes Babies Before Birth

A groundbreaking study by researchers at All India Institute of Medical Sciences (AIIMS Delhi) has revealed that air pollution can damage the placenta, restrict fetal growth, and increase pregnancy complications, with effects that may extend well beyond birth. The research, published in EMBO Molecular Medicine and funded by ICMR, examined how urban air pollution impacts […]
Article by: IMT News Desk
P. D. Hinduja Hospital & Dr. Homi Bhabha State University join hands to conduct specialized Postgraduate Allied Health Courses
News
June 9, 2026

P. D. Hinduja Hospital & Dr. Homi Bhabha State University join hands to conduct specialized Postgraduate Allied Health Courses

P. D. Hinduja Hospital & Medical Research Centre signed a memorandum of understanding with Dr. Homi Bhabha State University (HBSU) to jointly conduct postgraduate allied (paramedical) health courses. The MoU aims to address the growing demand for skilled healthcare professionals and strengthen the quality of paramedical education in India. The program, expected to commence in […]
Article by: IMT News Desk
Immuneel Therapeutics secures over ₹100 Crore Series B Funding
News
June 9, 2026

Immuneel Therapeutics secures over ₹100 Crore Series B Funding

Immuneel Therapeutics announced the successful close of its ₹100 crore plus Series B financing. The round saw participation from new investors, including Singularity AMC, Rainmatter by Zerodha, and several High-Net-Worth Individuals, alongside strong continued support from existing investors, including Kiran Mazumdar-Shaw, Eight Roads Ventures, and F-Prime Capital. The financing will directly fund key strategic priorities: […]
Article by: IMT News Desk